News

According to a recent survey from the Pistoia Alliance, AI and machine learning- ML are going to be the top technology investments when it comes to 60% of life sciences companies in the next two years. 1 With this growing...

Apparently, when a grocery store goes on to steeply discount rotting cuts of meat or produce, would one buy them? May be not. If we go by the same logic, if a pharmacy went ahead and sold medications that...

The year 2023 was indeed quite a challenging year for the life sciences industry, which was marked by a chilly biotech financing environment, uncertainty when it came to legislative and policy changes, as well as an unpredictable macroeconomic outlook....

The scenario is that the regulators are all ramping up pressure when it comes to the biopharma industry in 2024. Pharma companies not only happen to need to jump through new hoops when it comes to an increasingly intricate...

Prominent regulatory changes throughout the numerous medical fields are coming in 2024, with pharma and medical device companies urged to be on with a year of legal edits. Right from the UK’s reworking of the Voluntary Scheme for Branded Medicines-...

In the pharmaceutical industry, the process of manufacturing drugs for clinical trials differs significantly from the process of manufacturing drugs for commercial distribution. While both require adherence to good manufacturing practices (GMP), clinical manufacturing presents unique challenges that must...

Antimicrobial Resistance- AMR as it is referred to, is rising, and an AMR review that was commissioned by the UK Government has gone on to predict that by 2050, an additional 10 million people may as well succumb to...